The private, the public and the hybrid in umbilical cord blood banking – a global perspective

Article English OPEN
Sleeboom-Faulkner, Margaret ; Chang, Hung-Chieh (2016)
  • References (22)
    22 references, page 1 of 3

    [4] Martell K, Trounson E, Baum E. Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization. Cell Stem Cell 7(4), 451-454 (2010).

    [13] FDA. Accelerated Approval.

    http://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm

    [14] FDA. Breakthrough Therapies.

    http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstothe FDCAct/FDASIA/ucm329491.htm

    [15] FDA. Priority Review.

    http://www.fda.gov/ForPatients/Approvals/Fast/ucm405405.htm

    [42] Ministry of Science, Technology and Innovation of Argentina. Crece el debate sobre las terapias avanzadas en la Argentina. Press Release (2016).

    http://www.mincyt.gob.ar/_post/descargar.php?idAdjuntoArchivo=47765

    [43] Krmpotic C. Creer en la cura: Eficacia simbólica y control social en las prácticas del Dr. M., Scripta Ethnologica, 33, 97-116 (2011).

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    4
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Sussex Research Online - IRUS-UK 0 4
Share - Bookmark